Quintiles, the world’s largest life science services firm, is growing bigger. The RTP-based firm said Wednesday that it had acquired VCG & Associates, a Massachusetts-based provider of marketing and related services to life science companies.VCG BIO in Arizona is also part of the deal. The company, which is privately held as is Quintiles, has some 25 employees. Financial terms were not disclosed.
“VCG complements our solutions and capabilities within both our Commercial and Consulting divisions with emerging biopharma, companies looking to establish a commercial presence in the U.S., and drug development companies entering the commercial space for the first time,” said Rich Pilnik, president of Global Commercial Solutions for Quintiles. “By creating virtual companies – utilizing market access services, proven distribution channels and reimbursement strategies – biopharma can bring needed therapies to market faster and more efficiently.”
VCG works primarily with biopharmaceutical firms that are looking for help in broadening market access, distribution and reimbursements for products. The companies are familiar with each other.
“We have worked closely with Quintiles for the past several years, and this acquisition is a natural step that allows both organizations to serve our customers with specialized commercialization offerings,” said Brad Fleahman, co-founder and managing partner of VCG. “VCG will continue to provide our customers the same high level of service from our talented employees and trusted business operations and processes, while drawing upon Quintiles’ complementary expertise and services.”